SCHEMBL6599588

SCHEMBL6599588

COC(=O)c1cc2c(O)c(OC)ccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.55
MAPT P10636 5/20 0.49
KDM4E B2RXH2 4/20 0.49
RAB9A P51151 3/20 0.49
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
PKM P14618 1/20 0.49
HTT P42858 1/20 0.49
GLA P06280 1/20 0.48
GAA P10253 1/20 0.48
ULK1 O75385 1/20 0.47
FLT3 P36888 2/20 0.46
CYP1A2 P05177 1/20 0.45
HPGD P15428 2/20 0.44
XDH P47989 2/20 0.44
KMT2A Q03164 6/20 0.43
NPC1 O15118 2/20 0.43
POLB P06746 2/20 0.43
MAPK1 P28482 1/20 0.43
NTSR1 P30989 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9314516 0.86 KDM4E (0.60) IDO1MAPTKDM4ERAB9ALMNA
SCHEMBL5564109 0.85 KMT2A (0.57) MAPTKDM4ELMNASMN1; SMN2GLA
SCHEMBL19330914 0.84 GLA (0.47) MAPTKDM4ELMNASMN1; SMN2GLA
SCHEMBL30310487 0.84 GLA (0.47) MAPTKDM4ELMNASMN1; SMN2GLA
SCHEMBL11965472 0.84 GAA (0.47) IDO1MAPTKDM4ERAB9ALMNA
SCHEMBL14311096 0.81 ULK1 (0.49) IDO1MAPTKDM4ERAB9ALMNA
SCHEMBL6597101 0.80 KMT2A (0.50) MAPTKDM4ERAB9ALMNASMN1; SMN2
SCHEMBL217459 0.80 FLT3 (0.66) IDO1MAPTKDM4ERAB9ALMNA
SCHEMBL2760135 0.79 ULK1 (0.48) IDO1MAPTKDM4ERAB9ALMNA
SCHEMBL12641845 0.77 ULK1 (0.46) IDO1MAPTKDM4ERAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150954-B1 ANTI-IMFLAMMATORY INDOLE DERIVATIVES ASTRAZENECA AB (SE) 2004-10-13 EP disclosed
US-6569888-B1 Such as ethyl-N-(dichlorobenzyl)-4-(3-hydroxypropylthio) indole-2-carboxylate; for treatment of arthritis ASTRAZENECA AB (SE) 2003-05-27 US disclosed
EP-1150954-A1 ANTI-IMFLAMMATORY INDOLE DERIVATIVES AstraZeneca AB (SE) 2001-11-07 EP disclosed
WO-2000046198-A1 ANTI-INFLAMMATORY INDOLE DERIVATIVES ASTRAZENECA AB (SE) 2000-08-10 WO disclosed